Ponvory Reduces Risk of Worsening Disability & Managing Tomorrow’s Consequences

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on the effectiveness of Ponvory that has emerged from analyzing a database of multiple sclerosis clinical trials compiled by Certara.

He also reads “Tipping the Scale: When Today’s Choices Become Tomorrow’s Consequences”, from Beth Ullah’s column “Through the Looking Glass.”

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/